Zelira Therapeutics Ltd
F:G1G
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Shareholder Yield
Current shareholder yield for 
G1G is
.
Dividends, buybacks and debt paydown, as one yield.
Create a free account · No card needed
Create a free account · No card needed
Create a free account · No card needed
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
G1G Price
Zelira Therapeutics Ltd
| Average Annual Return | 1 359.03% |
| Standard Deviation of Annual Returns | 3 066.58% |
| Max Drawdown | -93% |
| Market Capitalization | 6.6m EUR |
| Shares Outstanding | 11 347 200 |
| Percentage of Shares Shorted |
N/A
|
G1G Return Decomposition
Main factors of price return
Stock Splits
G1G's latest stock split occurred on Apr 14, 2022
The company executed a 1-for-175 stock split, meaning that for every 175 shares held, investors received 1 new share.
Before the split, G1G traded at 1.5751 per share. Afterward, the share price was about 1.575.
The adjusted shares began trading on Apr 14, 2022. This was stock split number 3 in G1G's history, following the previous one in Oct 17, 2016.
